28 completed. 28 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 28 | Completed 28 |
| Phase 1 | 4 | Completed 4 |
Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis Cannabidiol Oil - Sleep Quality, Multiple Sclerosis | Phase 2 | Completed | Wageningen University | 16 | 2024-03-26 | 2026-09-25 |
| Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial Cannabidiol, Placebo - Brain Injuries, Traumatic | Phase 2 | Completed | University of Colorado, Denver | 43 | 2023-04-11 | 2025-12-17 |
| A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users cannabis 0 mg, placebo, Cannabis 20 mg,, Cannabis 50 mg - Cannabis | Phase 1 / Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 70 | 2022-07-22 | 2024-04-22 |
| Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy Cannabidiol, Placebo Administration, Quality-of-Life Assessment - Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm | Phase 2 | Completed | Mayo Clinic | 40 | 2022-06-09 | 2026-01-16 |
| Reducing Pain and Opioid Use With CBD Cannabidiol, Placebo - Opioid Use Disorder | Phase 2 | Completed | University of Colorado, Denver | 126 | 2022-03-08 | 2025-12-12 |
| Cannabidiol for Reduction of Brain Neuroinflammation CBD, Placebo - Back Pain, Depressive Symptoms | Phase 2 | Completed | Massachusetts General Hospital | 69 | 2022-01-04 | 2026-10-15 |
| CBD for the Treatment of Alcohol Use Disorder Cannabidiol, Placebo - Alcohol Use Disorder | Phase 2 | Completed | University of Colorado, Denver | 45 | 2021-08-30 | 2024-10-01 |
| Efficacy of Inhaled Cannabis for Acute Migraine Treatment THC ~5%, CBD ~12%, THC ~5% and CBD ~12% - Migraine, Cannabis | Phase 2 | Completed | University of California, San Diego | 92 | 2020-11-20 | 2023-02-28 |
| Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine Cannabidiol 600mg - Opioid-use Disorder | Phase 2 | Completed | Brigham and Women's Hospital | 8 | 2020-08-03 | 2023-05-18 |
| Is Topical CBD Effective in Treating Thumb Joint Arthritis CBD, Shea Butter - CBD, Hand Osteoarthritis | Phase 2 | Completed | University of Virginia | 18 | 2020-07-28 | 2025-07-03 |
| Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients CBD - Chronic Spontaneous Urticaria | Phase 2 | Completed | Stero Biotechs Ltd. | 15 | 2020-02-01 | 2024-04-18 |
| Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome Cannabidiol - Sturge-Weber Syndrome | Phase 2 | Completed | Anne Comi, MD | 11 | 2019-10-14 | 2023-05-25 |
| Cannabidiol and Prolonged Exposure Prolonged Exposure, Cannabidiol, placebo - PTSD | Phase 2 | Completed | VA Office of Research and Development | 136 | 2019-10-01 | 2026-10-28 |
| The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy CBD - Diabetic Neuropathies | Phase 2 | Completed | Pure Green | 32 | 2019-09-30 | 2019-12-11 |
| Cannabidiol as a Treatment for AUD Comorbid With PTSD Cannabidiol, Placebos - Alcohol Use Disorder, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | NYU Langone Health | 95 | 2019-09-16 | 2023-06-28 |
| CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. Cannabidiol, Placebo Oral Tablet - Psoriatic Arthritis, Hand Osteoarthritis | Phase 2 | Completed | Aalborg University Hospital | 136 | 2018-11-28 | 2021-07-07 |
| A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease Cannabidiol, Placebo - Parkinson Disease | Phase 2 | Completed | University of Colorado, Denver | 74 | 2018-09-05 | 2024-07-23 |
| An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy GWP42003-P - Epilepsy | Phase 2 | Completed | Jazz Pharmaceuticals | 30 | 2016-12-15 | 2022-12-20 |
| A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy GWP42003-P, Placebo - Epilepsy | Phase 2 | Completed | Jazz Pharmaceuticals | 35 | 2016-11-09 | 2022-12-20 |
| Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers Cannabidiol, Placebo - Pain | Phase 1 / Phase 2 | Completed | University of California, Los Angeles | 18 | 2016-07-01 | 2021-05-12 |
Showing 20 of 28. Sign in to see all of them.
Marijuana Abuse (7) · Opioid-Related Disorders (4) · Epilepsy (3) · Pain (3) · Alcoholism (2) · Diabetes Mellitus (2) · Psychotic Disorders (2) · Stress Disorders, Post-Traumatic (2) · Sturge-Weber Syndrome (2) · Anxiety Disorders (1) · Arthritis, Psoriatic (1) · Back Pain (1) · Brain Injuries, Traumatic (1) · Chronic Urticaria (1) · Cocaine-Related Disorders (1)
Jazz Pharmaceuticals (4) · University of Colorado, Denver (4) · Anne Comi, MD (2) · Centre hospitalier de l'Université de Montréal (CHUM) (2) · Hurd,Yasmin, Ph.D. (2) · Aalborg University Hospital (1) · Brigham and Women's Hospital (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · NYU Langone Health (1) · National Institute on Drug Abuse (NIDA) (1) · Pure Green (1) · Stero Biotechs Ltd. (1) · University of California, Los Angeles (1) · University of California, San Diego (1)
United States (19) · Netherlands (3) · Spain (3) · Canada (2) · Sweden (2) · United Kingdom (2) · Denmark (1) · Israel (1)
Anne M Comi, MD (2) · Brian Martis, MD (1) · Catherine R Ayers, PhD (1) · Charles Marmar, MD (1) · Debra Kimless, M.D. (1) · Didier Jutras-Aswad, MD,MS (1) · Didier Jutras-Aswad, MD,MS,FRCPC (1) · Joji Suzuki, M.D. (1) · Jonathan Vela (1) · Kent Hutchison, PhD (1) · Margaret Haney, M.D. (1) · Maureen Leehey (1) · Nathaniel M Schuster, MD (1) · Renger Witkamp, prof.dr. (1) · Robert J Malcolm, M.D. (1)
PMID 27573936, PMID 31109198, PMID 32350749, PMID 32652616, PMID 33464660, PMID 35135986, PMID 36105269, PMID 36123113, PMID 38466972, PMID 38770686, PMID 39016024, PMID 39719161, PMID 40357520, PMID 41469488, PMID 41514385, PMID 42454450
2015 (2), 2014 (1), R21DA027781 (1)